APO Research
Talk to an analyst

APO RESEARCH · REPORT

Malaria Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Malaria Drugs Industry Growth and Trends Forecast to 2032

20 December 2025109 pages

Choose your research edition.

Industry ResearchMalaria Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Malaria Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Malaria Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Malaria Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Malaria Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Malaria Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Malaria Drugs include Ajanta Pharma, Cipla, Guilin Pharmaceutical, IPCA Laboratories, Sanofi Aventis, GlaxoSmithKline, Kunming Pharmaceutical, Roche and Mylan Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Malaria Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Malaria Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Malaria Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Malaria Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Malaria Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Malaria Drugs Market by Company

Ajanta Pharma

Cipla

Guilin Pharmaceutical

IPCA Laboratories

Sanofi Aventis

GlaxoSmithKline

Kunming Pharmaceutical

Roche

Mylan Labs

Novartis

Malaria Drugs Segment by Type

Artemisinin Compounds

Antifolate Compounds

Aryl Aminoalcohol Compounds

Malaria Drugs Segment by Application

Prevention

Treatment

Other

Malaria Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Malaria Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Malaria Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Malaria Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Artemisinin Compounds Table 2. Major Company of Antifolate Compounds Table 3. Major Company of Aryl Aminoalcohol Compounds Table 4. Global Malaria Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Malaria Drugs Sales by Type (2021-2026) & (k units) Table 6. Global Malaria Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Malaria Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Malaria Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Malaria Drugs Price by Type (2021-2026) & (US$/unit) Table 10. Global Malaria Drugs Sales by Type (2027-2032) & (k units) Table 11. Global Malaria Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Malaria Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Malaria Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Malaria Drugs Price by Type (2027-2032) & (US$/unit) Table 15. North America Malaria Drugs Sales by Type (2021-2026) & (k units) Table 16. North America Malaria Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Malaria Drugs Sales by Type (2021-2026) & (k units) Table 18. Europe Malaria Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Malaria Drugs Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Malaria Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Malaria Drugs Sales by Type (2021-2026) & (k units) Table 22. Latin America Malaria Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Malaria Drugs Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Malaria Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Malaria Drugs Industry Trends Table 26. Malaria Drugs Industry Drivers Table 27. Malaria Drugs Industry Opportunities and Challenges Table 28. Malaria Drugs Industry Restraints Table 29. Global Malaria Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Malaria Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Malaria Drugs Sales by Company (2021-2026) & (k units) Table 32. Global Malaria Drugs Sales Share by Company (2021-2026) Table 33. Global Malaria Drugs Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Malaria Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Malaria Drugs Major Company Production Sites and Headquarters Table 36. Global Malaria Drugs Company, Product Type & Application Table 37. Global Malaria Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Malaria Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Malaria Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Malaria Drugs Sales by Region (2021-2026) & (k units) Table 42. Global Malaria Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Malaria Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Malaria Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Malaria Drugs Sales by Region (2027-2032) & (k units) Table 47. Global Malaria Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Malaria Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Malaria Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Malaria Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Malaria Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Malaria Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Malaria Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Malaria Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Malaria Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Malaria Drugs Sales by Application (2027-2032) & (k units) Table 58. Global Malaria Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Malaria Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Malaria Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Malaria Drugs Price by Application (2027-2032) & (US$/unit) Table 62. North America Malaria Drugs Sales by Application (2021-2026) & (k units) Table 63. North America Malaria Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Malaria Drugs Sales by Application (2021-2026) & (k units) Table 65. Europe Malaria Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Malaria Drugs Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Malaria Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Malaria Drugs Sales by Application (2021-2026) & (k units) Table 69. Latin America Malaria Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Malaria Drugs Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Malaria Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Ajanta Pharma Company Information Table 73. Ajanta Pharma Business Overview Table 74. Ajanta Pharma Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Ajanta Pharma Malaria Drugs Product Portfolio Table 76. Ajanta Pharma Recent Development Table 77. Cipla Company Information Table 78. Cipla Business Overview Table 79. Cipla Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Cipla Malaria Drugs Product Portfolio Table 81. Cipla Recent Development Table 82. Guilin Pharmaceutical Company Information Table 83. Guilin Pharmaceutical Business Overview Table 84. Guilin Pharmaceutical Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Guilin Pharmaceutical Malaria Drugs Product Portfolio Table 86. Guilin Pharmaceutical Recent Development Table 87. IPCA Laboratories Company Information Table 88. IPCA Laboratories Business Overview Table 89. IPCA Laboratories Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. IPCA Laboratories Malaria Drugs Product Portfolio Table 91. IPCA Laboratories Recent Development Table 92. Sanofi Aventis Company Information Table 93. Sanofi Aventis Business Overview Table 94. Sanofi Aventis Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Sanofi Aventis Malaria Drugs Product Portfolio Table 96. Sanofi Aventis Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Malaria Drugs Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Kunming Pharmaceutical Company Information Table 103. Kunming Pharmaceutical Business Overview Table 104. Kunming Pharmaceutical Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Kunming Pharmaceutical Malaria Drugs Product Portfolio Table 106. Kunming Pharmaceutical Recent Development Table 107. Roche Company Information Table 108. Roche Business Overview Table 109. Roche Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Roche Malaria Drugs Product Portfolio Table 111. Roche Recent Development Table 112. Mylan Labs Company Information Table 113. Mylan Labs Business Overview Table 114. Mylan Labs Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Mylan Labs Malaria Drugs Product Portfolio Table 116. Mylan Labs Recent Development Table 117. Novartis Company Information Table 118. Novartis Business Overview Table 119. Novartis Malaria Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Novartis Malaria Drugs Product Portfolio Table 121. Novartis Recent Development Table 122. North America Malaria Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. North America Malaria Drugs Sales by Country (2021-2026) & (k units) Table 124. North America Malaria Drugs Sales Market Share by Country (2021-2026) Table 125. North America Malaria Drugs Sales Forecast by Country (2027-2032) & (k units) Table 126. North America Malaria Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. North America Malaria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Malaria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Malaria Drugs Market Share by Country (2021-2026) Table 130. North America Malaria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Malaria Drugs Market Share Forecast by Country (2027-2032) Table 132. Europe Malaria Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Europe Malaria Drugs Sales by Country (2021-2026) & (k units) Table 134. Europe Malaria Drugs Sales Market Share by Country (2021-2026) Table 135. Europe Malaria Drugs Sales Forecast by Country (2027-2032) & (k units) Table 136. Europe Malaria Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Malaria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Malaria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Malaria Drugs Market Share by Country (2021-2026) Table 140. Europe Malaria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Malaria Drugs Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Malaria Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Malaria Drugs Sales by Country (2021-2026) & (k units) Table 144. Asia-Pacific Malaria Drugs Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Malaria Drugs Sales Forecast by Country (2027-2032) & (k units) Table 146. Asia-Pacific Malaria Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Malaria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Malaria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Malaria Drugs Market Share by Country (2021-2026) Table 150. Asia-Pacific Malaria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Malaria Drugs Market Share Forecast by Country (2027-2032) Table 152. Latin America Malaria Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Latin America Malaria Drugs Sales by Country (2021-2026) & (k units) Table 154. Latin America Malaria Drugs Sales Market Share by Country (2021-2026) Table 155. Latin America Malaria Drugs Sales Forecast by Country (2027-2032) & (k units) Table 156. Latin America Malaria Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Malaria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Malaria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Malaria Drugs Market Share by Country (2021-2026) Table 160. Latin America Malaria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Malaria Drugs Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Malaria Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Malaria Drugs Sales by Country (2021-2026) & (k units) Table 164. Middle East and Africa Malaria Drugs Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Malaria Drugs Sales Forecast by Country (2027-2032) & (k units) Table 166. Middle East and Africa Malaria Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Malaria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Malaria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Malaria Drugs Market Share by Country (2021-2026) Table 170. Middle East and Africa Malaria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Malaria Drugs Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Malaria Drugs Distributors List Table 175. Malaria Drugs Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Malaria Drugs Image Figure 2. Global Malaria Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Malaria Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Malaria Drugs Sales (2021-2032) & (k units) Figure 5. Artemisinin Compounds Image Figure 6. Global Artemisinin Compounds Sales YoY Growth (2021-2032) & (k units) Figure 7. Antifolate Compounds Image Figure 8. Global Antifolate Compounds Sales YoY Growth (2021-2032) & (k units) Figure 9. Aryl Aminoalcohol Compounds Image Figure 10. Global Aryl Aminoalcohol Compounds Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Malaria Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Malaria Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Malaria Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Malaria Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Malaria Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Malaria Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Malaria Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Malaria Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Malaria Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Malaria Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Malaria Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Malaria Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Malaria Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Prevention Image Figure 26. Global Prevention Sales YoY Growth (2021-2032) & (k units) Figure 27. Treatment Image Figure 28. Global Treatment Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Malaria Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Malaria Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Malaria Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Malaria Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Malaria Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Malaria Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Malaria Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Malaria Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Malaria Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Malaria Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Malaria Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Malaria Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Malaria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Malaria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Malaria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Malaria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Malaria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Malaria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Malaria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Malaria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Malaria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Malaria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Malaria Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Malaria Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Artemisinin Compounds
  • Antifolate Compounds
  • Aryl Aminoalcohol Compounds
Applications
  • Prevention
  • Treatment
  • Other
Companies covered
  • Ajanta Pharma
  • Cipla
  • Guilin Pharmaceutical
  • IPCA Laboratories
  • Sanofi Aventis
  • GlaxoSmithKline
  • Kunming Pharmaceutical
  • Roche
  • Mylan Labs
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Malaria Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Malaria Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Malaria Drugs Market by Type
  6. 1.3.1 Artemisinin Compounds
  7. 1.3.2 Antifolate Compounds
  8. 1.3.3 Aryl Aminoalcohol Compounds
  9. 1.4 Global Malaria Drugs Market Size by Type
  10. 1.4.1 Global Malaria Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Malaria Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Malaria Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Malaria Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Malaria Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Malaria Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Malaria Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Malaria Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Malaria Drugs Industry Trends
  2. 2.2 Malaria Drugs Industry Drivers
  3. 2.3 Malaria Drugs Industry Opportunities and Challenges
  4. 2.4 Malaria Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Malaria Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Malaria Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Malaria Drugs Price (2021-2026)
  4. 3.4 Global Malaria Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Malaria Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Malaria Drugs Company, Product Type & Application
  7. 3.7 Global Malaria Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Malaria Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Malaria Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Malaria Drugs Tier 1, Tier 2, and Tier 3
4 Malaria Drugs Regional Status and Outlook
  1. 4.1 Global Malaria Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Malaria Drugs Historic Market Size by Region
  3. 4.2.1 Global Malaria Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Malaria Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Malaria Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Malaria Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Malaria Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Malaria Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Malaria Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Malaria Drugs by Application
  1. 5.1 Malaria Drugs Market by Application
  2. 5.1.1 Prevention
  3. 5.1.2 Treatment
  4. 5.1.3 Other
  5. 5.2 Global Malaria Drugs Market Size by Application
  6. 5.2.1 Global Malaria Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Malaria Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Malaria Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Malaria Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Malaria Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Malaria Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Malaria Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Malaria Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ajanta Pharma
  2. 6.1.1 Ajanta Pharma Company Information
  3. 6.1.2 Ajanta Pharma Business Overview
  4. 6.1.3 Ajanta Pharma Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ajanta Pharma Malaria Drugs Product Portfolio
  6. 6.1.5 Ajanta Pharma Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Malaria Drugs Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Guilin Pharmaceutical
  14. 6.3.1 Guilin Pharmaceutical Company Information
  15. 6.3.2 Guilin Pharmaceutical Business Overview
  16. 6.3.3 Guilin Pharmaceutical Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guilin Pharmaceutical Malaria Drugs Product Portfolio
  18. 6.3.5 Guilin Pharmaceutical Recent Developments
  19. 6.4 IPCA Laboratories
  20. 6.4.1 IPCA Laboratories Company Information
  21. 6.4.2 IPCA Laboratories Business Overview
  22. 6.4.3 IPCA Laboratories Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 IPCA Laboratories Malaria Drugs Product Portfolio
  24. 6.4.5 IPCA Laboratories Recent Developments
  25. 6.5 Sanofi Aventis
  26. 6.5.1 Sanofi Aventis Company Information
  27. 6.5.2 Sanofi Aventis Business Overview
  28. 6.5.3 Sanofi Aventis Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Aventis Malaria Drugs Product Portfolio
  30. 6.5.5 Sanofi Aventis Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Malaria Drugs Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Kunming Pharmaceutical
  38. 6.7.1 Kunming Pharmaceutical Company Information
  39. 6.7.2 Kunming Pharmaceutical Business Overview
  40. 6.7.3 Kunming Pharmaceutical Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kunming Pharmaceutical Malaria Drugs Product Portfolio
  42. 6.7.5 Kunming Pharmaceutical Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche Malaria Drugs Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Mylan Labs
  50. 6.9.1 Mylan Labs Company Information
  51. 6.9.2 Mylan Labs Business Overview
  52. 6.9.3 Mylan Labs Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Labs Malaria Drugs Product Portfolio
  54. 6.9.5 Mylan Labs Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Malaria Drugs Product Portfolio
  60. 6.10.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Malaria Drugs Sales by Country
  2. 7.1.1 North America Malaria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Malaria Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Malaria Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Malaria Drugs Market Size by Country
  6. 7.2.1 North America Malaria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Malaria Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Malaria Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Malaria Drugs Sales by Country
  2. 8.1.1 Europe Malaria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Malaria Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Malaria Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Malaria Drugs Market Size by Country
  6. 8.2.1 Europe Malaria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Malaria Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Malaria Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Malaria Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Malaria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Malaria Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Malaria Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Malaria Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Malaria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Malaria Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Malaria Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Malaria Drugs Sales by Country
  2. 10.1.1 South America Malaria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Malaria Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Malaria Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Malaria Drugs Market Size by Country
  6. 10.2.1 South America Malaria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Malaria Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Malaria Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Malaria Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Malaria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Malaria Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Malaria Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Malaria Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Malaria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Malaria Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Malaria Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Malaria Drugs Value Chain Analysis
  2. 12.1.1 Malaria Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Malaria Drugs Production Mode & Process
  7. 12.2 Malaria Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Malaria Drugs Distributors
  10. 12.2.3 Malaria Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst